Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization

BACKGROUND: During the past few years, immune cell therapy for malignant cancer has benefited a considerable amount of patients worldwide. As one of several promising candidates for immunotherapy, Vγ9Vδ2 γδ T cells have many unique biological advantages, such as non-MHC restriction and have been not...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Li, He, Junyi, Li, Jiawei, Xu, Yan, Li, Jingxia, Wu, Yangzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890518/
https://www.ncbi.nlm.nih.gov/pubmed/31819434
http://dx.doi.org/10.2147/IJN.S212898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890518/
https://www.ncbi.nlm.nih.gov/pubmed/31819434
http://dx.doi.org/10.2147/IJN.S212898

Ejemplares similares